Wang YY#, Xiang BD#, Ma L, Zhong JH, Ye JZ, Wang K, Xing BC* and Li LQ*. Development and Validation of a Nomogram to Preoperatively Estimate Post-hepatectomy Liver Dysfunction Risk and Long-term Survival in Patients With Hepatocellular Carcinoma,Ann Surg,Online ahead of print.

Jin KM, Liu W, Wang K, Bao Q, Wang HW and Xing BC*. The individualized selection of Pancreaticoenteric anastomosis in Pancreaticoduodenectomy,BMC Surg,2020, 20(1): 140.

Liu X, Xu D, Liu Z, Li Y, Zhang C, Gong Y, Jiang Y and Xing B*. THBS1 facilitates colorectal liver metastasis through enhancing epithelial-mesenchymal transition,Clin Transl Oncol,Online ahead of print.

Wang LJ, Wang HW, Jin KM, Li J and Xing BC*. Comparison of sequential, delayed and simultaneous resection strategies for synchronous colorectal liver metastases,BMC Surg,2020, 20(1): 16.

Wang LJ, Yan XL, Li J, Wang K and Xing BC*. Indocyanine Green Clearance Test for the Preoperative Assessment of Chemotherapy-Related Hepatic Injury in Patients with Colorectal Liver Metastasis,Cancer Manag Res,2020, 12: 3237-3245.

Liu W, Wang HW, Wang K and Xing BC*. The primary tumor location impacts survival outcome of colorectal liver metastases after hepatic resection: A systematic review and meta-analysis,Eur J Surg Oncol,45(8):1349-1356.

Liu W, Wang K, Han Y, Liang JY, Li YH and Xing BC*. Nomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection,Eur J Surg Oncol,45(11):2070-2077.

Liu Z, Liu X, Li Y, Ren P, Zhang C, Wang L, Du X* and Xing B*. miR-6716-5p promotes metastasis of colorectal cancer through downregulating NAT10 expression,Cancer Manag Res,2019,11:5317-5332.

Ren P, Sun X, Zhang C, Wang L, Xing B* and Du X*. Human UTP14a promotes angiogenesis through upregulating PDGFA expression in colorectal cancer,Biochem Biophys Res Commun,512(4):871-876.

Wang J#, Xing B#, Liu W, Li J, Wang X, Li J, Yang J, Ji C, Li Z, Dong B, Gao J and Shen L. Molecularly annotation of mouse avatar models derived from patients with colorectal cancer liver metastasis,Theranostics,9(12): 3485-3500.

Wang YY, Liu ZZ, Xu D, Liu M, Wang K and Xing BC*. Fibrinogen-Albumin Ratio Index (FARI): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Hepatectomy for Colorectal Liver Metastases,Ann Surg Oncol,26(11):3682-3692.

Wang YY, Wang LJ, Xu D, Liu M, Wang HW, Wang K, Zhu X, Xing BC*. Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion,HPB (Oxford),21(4):425-433.

Jiang Y#, Sun A#, Zhao Y#, Ying W#, Sun H#, Yang X#, Xing B#, Sun W, Ren L, Hu B, Li C, Zhang L, Qin G, Zhang M, Chen N, Zhang M, Huang Y, Zhou J, Zhao Y, Liu M, Zhu X, Qiu Y, Sun Y, Huang C, Yan M, Wang M, Liu W, Tian F, Xu H, Zhou J, Wu Z, Shi T, Zhu W, Qin J, Xie L, Fan J, Qian X, He F. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma,Nature,567(7747):257-261.

Wang YY, Zhong JH, Mao YL, Li LQ, Xing BC*. Editorial: redrawing the boundaries for surgical intervention in hepatocellular carcinoma-authors' reply,Aliment Pharmacol Ther,49(5):616-617.

Xu D, Wang HW, Yan XL, Li J, Wang K, Xing BC*. Sub-millimeter surgical margin is acceptable in patients with good tumor biology after liver resection for colorectal liver metastases,Eur J Surg Oncol,45(9):1551-1558.

Wang YY, Zhong JH, Xu HF, Xu G, Wang LJ, Xu D, Wang HW, Wang K, Xiang BD, Mao YL*, Li LQ*, Xing BC*. A modified staging of early and intermediate hepatocellular carcinoma based on single tumour >7 cm and multiple tumours beyond up-to-seven criteria,Aliment Pharmacol Ther,49(2):202-210.

Zhang J, Ren P, Xu D, Liu X, Liu Z, Zhang C, Li Y, Wang L, Du X*, Xing B*. Human UTP14a promotes colorectal cancer progression by forming a positive regulation loop with c-Myc,Cancer Lett,440-441:106-115.

Xu D#, Liu X#, Wang L, Xing B*. Hepatectomy plus adjuvant transcatheter arterial chemoembolization improves the survival rate of patients with multicentric occurrence of hepatocellular carcinoma,Oncol Lett,16(5):5882-5890.

Wang LJ, Zhang ZY, Yan XL, Yang W, Yan K, Xing BC*. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis,World J Surg Oncol,16(1):207.

Liu X, Cai S, Zhang C, Liu Z, Luo J, Xing B*, Du X*. Deacetylation of NAT10 by Sirt1 promotes the transition from rRNA biogenesis to autophagy upon energy stress,Nucleic Acids Res,46(18):9601-9616.

Wang K, Xu D, Yan XL, Poston G, Xing BC*. The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis,Eur J Surg Oncol,44(6):771-777.

Zhang J, Hao N, Liu W, Lu M, Sun L, Chen N, Wu M, Zhao X, Xing B*, Sun W*, He F*. In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery,Br J Cancer,117(11):1676-1684.

Zhang JY, Xu D, Liu ZZ, Li Y, Wang LJ, Xing BC*. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis,Chin Med J (Engl),130(4):470-476.

Li Q, Liu X, Jin K, Lu M, Zhang C, Du X, Xing B*. NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity,BMC Cancer,17(1):605.

Wang K, Liu W, Yan XL, Li J, Xing BC*. Long-term postoperative survival prediction in patients with colorectal liver metastasis,Oncotarget,8(45):79927-79934.

Xu D, Liu XF, Yan XL, Wang K*, Xing BC*. Survival prediction in patients with resectable colorectal liver metastases: Clinical risk scores and tumor response to chemotherapy,Oncol Lett,14(6):8051-8059.

刘铭, 王崑, 孙谊, 王宏伟, 包全, 金克敏, 姚云峰, 李健, 崔湧, 吴楠, 邢宝才*.排粪习惯改变3年,血便1年,检查发现直肠上段癌伴同时性肝转移2周,中华胃肠外科杂志,2017,20(8):941-944

刘兆君, 刘伟, 崔成华, 谷连坤, 邢宝才*, 邓大君*.A激酶锚定蛋白12基因甲基化与原发性肝癌复发的关系研究,中华预防医学杂志,2017,51(9):848-852

刘铭, 邢宝才*.保留肝实质的理念在结直肠癌肝转移治疗中的应用,肝癌电子杂志,2017,4(3):6-10

刘铭, 王崑, 包全, 王宏伟, 金克敏, 闫晓峦, 邢宝才*.保留肝实质的治疗方式在结直肠癌肝转移手术切除中的应用分析,中国肿瘤临床,2017,44(23):1179-1183

Cui C, Lu Z, Yang L, Gao Y, Liu W, Gu L, Yang C, Wilson J, Zhang Z, Xing B*, Deng D*, Sun ZS. Genome-wide identification of differential methylation between primary and recurrent hepatocellular carcinomas.,Molecular Carcinogenesis,2016;55(7):1163-74.

Liu W, Wang N, Lu M, Du XJ*, Xing BC*. MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection,Molecular medicine reports,2016;14(2):1617-23.

Sun W#, Xing B#, Guo L#, Liu Z#, Mu J#, Sun L, Wei H, Zhao X, Qian X, Jiang Y, He F. Quantitative Proteomics Analysis of Tissue Interstitial Fluid for Identification of Novel Serum Candidate Diagnostic Marker for Hepatocellular Carcinoma.,Scientific Reports,2016;6:26499.

Liu W, Zhou J G, Sun Y, Xing BC*, et al. The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis,Oncotarget,24(7):37277-37287

Wang K, Liu W, Yan X L, Xing BC*, et al. Role of a liver-first approach for synchronous colorectal liver metastases,World J Gastroenterol,22(6):2126-2132

Liu W, Wang K, Bao Q, Xing BC*, et al. Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma,World J Surg Oncol,14(1):62

住院医师规范化培训师资培训班 , 考核考官模块学习 , 第1完成人 , 北京医学教育协会 , 2017.1

原发性肝癌预后的生物学研究

肝癌临床样本库建设, 子课题负责人 , 2018.11.1～2020.12.31, 科技重大专项重大传染病防治专项（A001838）

肝癌精准近红外荧光成像术中导航系统的临床应用, 课题负责人 , 2019.12.1～2021.12.31, 国家重点研发计划

一个核仁蛋白在小鼠胚胎成血成血管和人肿瘤血管新生中的作用及机制研究, 课题负责人 , 2019.1.1～2022.12.31, 国家自然科学基金委

hUTP14a通过调节血管生成促进结直肠癌转移, 课题负责人 , 2019.1.1～2021.12.31, 北京市自然科学基金

肝动脉灌注化疗联合系统化疗用于结直肠癌肝转移术后辅助治疗的多中心前瞻性随机对照临床研究, 子课题负责人 , 2018.1.1～2020.12.31, 首都卫生发展科研专项

hALP作为结直肠癌肝转移肿瘤标志物以及作用机理研究 , 课题负责人 , 2014.1.1～2017.12.31, 国家自然科学基金

人体消化腺蛋白质组表达谱 , 子课题负责人 , 2015.3.5～2018.8.31, 973计划

研究生招生计划

招生年度	招生专业	学位级别	学位类型	研究方向	选拔方式
2021	肿瘤外科学	长学制	专业学位	临床技能训练与研究	长学制二级学科培养
2021	肿瘤学	博士	科学学位	结直肠癌肝转移发生机制的研究	申请考核制
2021	肿瘤外科学	博士	专业学位	临床技能训练与研究	申请考核制